We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$229M
1-Year Est. Return
22.02%
This Fund
S&P 500
This Quarter
Est. Return
+16.99%
1 Year Est. Return
+22.02%
3 Year Est. Return
+55.73%
5 Year Est. Return
+56.97%
10 Year Est. Return
–
AUM
$691M
AUM Growth
+$78M
(+13%)
Cap. Flow
+$88.8M
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.5M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$54.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.9M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$16.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$49.3M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$29.8M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$24.1M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$21.5M |
| 5 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 28.66% |
| 2 | Miscellaneous | 22.99% |
| 3 | Technology | 9.15% |
| 4 | Healthcare | 8.01% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Martin Marietta Materials
MLM
$36.1B
| $1.14M | 0.16% |
+5,518
| New | +$1.06M |
|
102
Philip Morris
PM
$290B
| $1.13M | 0.16% |
16,070
+1,201
| +8% | +$87.6K |
|
103
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$244M
| $1.12M | 0.16% |
+44,385
| New | +$1.3M |
|
104
Revvity
RVTY
$14.6B
| $1.11M | 0.16% |
+11,314
| New | +$1.03M |
|
105
AbbVie
ABBV
$460B
| $1.09M | 0.16% |
11,129
-2,747
| -20% | -$242K |
|
106
DuPont de Nemours
DD
$17.7B
| $1.09M | 0.16% |
16,363
-10,037
| -38% | -$586K |
|
107
British American Tobacco
BTI
$121B
| $1.07M | 0.16% |
27,674
-500
| -2% | -$19.2K |
|
108
GoDaddy
GDDY
$13.1B
| $1.05M | 0.15% |
+14,361
| New | +$1.03M |
|
109
Abbott
ABT
$188B
| $1.03M | 0.15% |
11,312
+609
| +6% | +$55K |
|
110
Capital One
COF
$135B
| $1.01M | 0.15% |
16,211
-301
| -2% | -$18.7K |
|
111
Honeywell
HON
$65.8B
| $998K | 0.14% |
7,322
-45
| -0.6% | -$5.96K |
|
112
Procter & Gamble
PG
$341B
| $991K | 0.14% |
8,284
-1,452
| -15% | -$169K |
|
113
SS&C Technologies
SSNC
$19.9B
| $978K | 0.14% |
+17,320
| New | +$944K |
|
114
Walt Disney
DIS
$185B
| $976K | 0.14% |
8,748
+35
| +0.4% | +$3.86K |
|
115
Accenture
ACN
$118B
| $961K | 0.14% |
4,475
+54
| +1% | +$10.2K |
|
116
Jacobs Solutions
J
$17.3B
| $955K | 0.14% |
+13,611
| New | +$918K |
|
117
ProShares Short S&P500
SH
$855M
| $934K | 0.14% |
5,043
+765
| +18% | +$73.5K |
|
118
Cincinnati Financial
CINF
$26.8B
| $904K | 0.13% |
14,129
+14,045
| +16,720% | +$927K |
|
119
SLB Ltd
SLB
$85.2B
| $887K | 0.13% |
48,218
-1,050
| -2% | -$18.4K |
|
120
Nike
NKE
$57.5B
| $869K | 0.13% |
8,863
-2,452
| -22% | -$226K |
|
121
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $865K | 0.13% |
+14,274
| New | +$847K |
|
|
EVBG
122
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $858K | 0.12% |
+6,202
| New | +$806K |
|
123
Amphenol
APH
$202B
| $855K | 0.12% |
+71,416
| New | +$797K |
|
124
American International
AIG
$40.2B
| $845K | 0.12% |
27,224
-896
| -3% | -$25.2K |
|
|
PARA
125
DELISTED
Paramount Global Class B
PARA
| $837K | 0.12% |
35,876
-4,030
| -10% | -$77.7K |
|
Similar funds
IAAG
AAG
WCM
PPA
DCC
SWIM
PRRFG
CAIM
tru Independence's Q2 2020 Portfolio in Review
As of Q2 2020, tru Independence held 960 positions worth $691M, up 13% from $613M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
tru Independence deployed $88.8M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.8% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.
- tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
- tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
- tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
- tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3M.
- tru Independence's ten largest holdings make up 41% of its $691M portfolio in Q2 2020.
- tru Independence opened 207 new positions and closed 53 in Q2 2020.
- tru Independence's portfolio value rose 13% quarter-over-quarter to $691M.
Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.